R.F. Lafferty & Co., Inc. is acting as the sole book-running manager for the offering.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARTL:
- Artelo Biosciences presents interim Phase 2 CAReS data on ART27.13
- Artelo Biosciences Completes Stock Offering with Over-Allotment
- Artelo Biosciences announces publication of preclinical data on ART12.11
- Artelo Biosciences Updates Bylaws on September 9, 2025
- Alphabet downgraded, Boeing upgraded: Wall Street’s top analyst calls